NIIMBL Seeks Advanced Biopharma Manufacturing Proposals To Fund
Executive Summary
The public-private partnership has $5.5m for grants to develop continuous manufacturing methods, cell/gene therapy platforms and other biopharmaceutical manufacturing innovations.